APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology Based Preclinical CRO

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.

Selected research

Market Structure

Global Oncology Based Preclinical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025197 pages

Choose your research edition.

Industry ResearchOncology Based Preclinical CRO Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology Based Preclinical CRO Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oncology Based Preclinical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology Based Preclinical CRO Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology Based Preclinical CRO Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.

The industry's leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.

Report Includes

Read the full market overview

This report provides an overview of the global Oncology Based Preclinical CRO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oncology Based Preclinical CRO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oncology Based Preclinical CRO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oncology Based Preclinical CRO market size, projected growth trends, production technologies, key applications, and end-use industries.

Oncology Based Preclinical CRO Segment by Company

Crown Bioscience

Charles River

ICON

Eurofins Scientific

Taconic Biosciences

Covance

EVOTEC

The Jackson Laboratory

MI Bioresearch

Champion Oncology

Wuxi AppTec.

Xentech

Living Tumor Laboratory

Oncology Based Preclinical CRO Segment by Type

Blood Cancer

Solid Tumors

Others

Oncology Based Preclinical CRO Segment by Application

In Vitro

In Vivo

Oncology Based Preclinical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Based Preclinical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology Based Preclinical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Based Preclinical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oncology Based Preclinical CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oncology Based Preclinical CRO industry.

Chapter 3: Detailed analysis of Oncology Based Preclinical CRO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Based Preclinical CROrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oncology Based Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Blood Cancer Table 3. Key Players of Solid Tumors Table 4. Key Players of Others Table 4. Global Oncology Based Preclinical CRO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of In Vitro Table 6. Key Players of In Vivo Table 7. Global Oncology Based Preclinical CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Oncology Based Preclinical CRO Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Oncology Based Preclinical CRO Market Share by Region (2021-2026) Table 10. Global Oncology Based Preclinical CRO Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Oncology Based Preclinical CRO Market Share by Region (2027-2032) Table 12. Oncology Based Preclinical CRO Industry Trends Table 13. Oncology Based Preclinical CRO Industry Drivers Table 14. Oncology Based Preclinical CRO Industry Opportunities and Challenges Table 15. Oncology Based Preclinical CRO Industry Restraints Table 16. Global Oncology Based Preclinical CRO Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Oncology Based Preclinical CRO Revenue Market Share by Company (2021-2026) Table 18. Global Oncology Based Preclinical CRO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Oncology Based Preclinical CRO Key Company Head Office and Area Served Table 20. Global Oncology Based Preclinical CRO Company, Product Type & Application Table 21. Global Oncology Based Preclinical CRO Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Oncology Based Preclinical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Oncology Based Preclinical CRO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oncology Based Preclinical CRO Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Oncology Based Preclinical CRO Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2021-2026) Table 28. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2027-2032) Table 29. Global Oncology Based Preclinical CRO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Oncology Based Preclinical CRO Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Oncology Based Preclinical CRO Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2021-2026) Table 33. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2027-2032) Table 34. Crown Bioscience Company Information Table 35. Crown Bioscience Business Overview Table 36. Crown Bioscience Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Crown Bioscience Oncology Based Preclinical CRO Product Portfolio Table 38. Crown Bioscience Recent Development Table 39. Charles River Company Information Table 40. Charles River Business Overview Table 41. Charles River Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Charles River Oncology Based Preclinical CRO Product Portfolio Table 43. Charles River Recent Development Table 44. ICON Company Information Table 45. ICON Business Overview Table 46. ICON Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. ICON Oncology Based Preclinical CRO Product Portfolio Table 48. ICON Recent Development Table 49. Eurofins Scientific Company Information Table 50. Eurofins Scientific Business Overview Table 51. Eurofins Scientific Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Eurofins Scientific Oncology Based Preclinical CRO Product Portfolio Table 53. Eurofins Scientific Recent Development Table 54. Taconic Biosciences Company Information Table 55. Taconic Biosciences Business Overview Table 56. Taconic Biosciences Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Taconic Biosciences Oncology Based Preclinical CRO Product Portfolio Table 58. Taconic Biosciences Recent Development Table 59. Covance Company Information Table 60. Covance Business Overview Table 61. Covance Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Covance Oncology Based Preclinical CRO Product Portfolio Table 63. Covance Recent Development Table 64. EVOTEC Company Information Table 65. EVOTEC Business Overview Table 66. EVOTEC Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. EVOTEC Oncology Based Preclinical CRO Product Portfolio Table 68. EVOTEC Recent Development Table 69. The Jackson Laboratory Company Information Table 70. The Jackson Laboratory Business Overview Table 71. The Jackson Laboratory Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. The Jackson Laboratory Oncology Based Preclinical CRO Product Portfolio Table 73. The Jackson Laboratory Recent Development Table 74. MI Bioresearch Company Information Table 75. MI Bioresearch Business Overview Table 76. MI Bioresearch Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. MI Bioresearch Oncology Based Preclinical CRO Product Portfolio Table 78. MI Bioresearch Recent Development Table 79. Champion Oncology Company Information Table 80. Champion Oncology Business Overview Table 81. Champion Oncology Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Champion Oncology Oncology Based Preclinical CRO Product Portfolio Table 83. Champion Oncology Recent Development Table 84. Wuxi AppTec. Company Information Table 85. Wuxi AppTec. Business Overview Table 86. Wuxi AppTec. Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Wuxi AppTec. Oncology Based Preclinical CRO Product Portfolio Table 88. Wuxi AppTec. Recent Development Table 89. Xentech Company Information Table 90. Xentech Business Overview Table 91. Xentech Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Xentech Oncology Based Preclinical CRO Product Portfolio Table 93. Xentech Recent Development Table 94. Living Tumor Laboratory Company Information Table 95. Living Tumor Laboratory Business Overview Table 96. Living Tumor Laboratory Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Living Tumor Laboratory Oncology Based Preclinical CRO Product Portfolio Table 98. Living Tumor Laboratory Recent Development Table 99. North America Oncology Based Preclinical CRO Market Size by Type (2021-2026) & (US$ Million) Table 100. North America Oncology Based Preclinical CRO Market Size by Type (2027-2032) & (US$ Million) Table 101. North America Oncology Based Preclinical CRO Market Size by Application (2021-2026) & (US$ Million) Table 102. North America Oncology Based Preclinical CRO Market Size by Application (2027-2032) & (US$ Million) Table 103. North America Oncology Based Preclinical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Oncology Based Preclinical CRO Market Size by Country (2021-2026) Table 105. North America Oncology Based Preclinical CRO Market Size by Country (2027-2032) Table 106. Europe Oncology Based Preclinical CRO Market Size by Type (2021-2026) & (US$ Million) Table 107. Europe Oncology Based Preclinical CRO Market Size by Type (2027-2032) & (US$ Million) Table 108. Europe Oncology Based Preclinical CRO Market Size by Application (2021-2026) & (US$ Million) Table 109. Europe Oncology Based Preclinical CRO Market Size by Application (2027-2032) & (US$ Million) Table 110. Europe Oncology Based Preclinical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Oncology Based Preclinical CRO Market Size by Country (2021-2026) Table 112. Europe Oncology Based Preclinical CRO Market Size by Country (2027-2032) Table 113. China Oncology Based Preclinical CRO Market Size by Type (2021-2026) & (US$ Million) Table 114. China Oncology Based Preclinical CRO Market Size by Type (2027-2032) & (US$ Million) Table 115. China Oncology Based Preclinical CRO Market Size by Application (2021-2026) & (US$ Million) Table 116. China Oncology Based Preclinical CRO Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Oncology Based Preclinical CRO Market Size by Type (2021-2026) & (US$ Million) Table 118. Asia Oncology Based Preclinical CRO Market Size by Type (2027-2032) & (US$ Million) Table 119. Asia Oncology Based Preclinical CRO Market Size by Application (2021-2026) & (US$ Million) Table 120. Asia Oncology Based Preclinical CRO Market Size by Application (2027-2032) & (US$ Million) Table 121. Asia Oncology Based Preclinical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Oncology Based Preclinical CRO Market Size by Country (2021-2026) Table 123. Asia Oncology Based Preclinical CRO Market Size by Country (2027-2032) Table 124. South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2021-2026) & (US$ Million) Table 127. South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2027-2032) & (US$ Million) Table 128. South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2021-2026) Table 130. South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Oncology Based Preclinical CRO Product Image Figure 2. Global Oncology Based Preclinical CRO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oncology Based Preclinical CRO Market Share by Type: 2025 VS 2032 Figure 4. Blood Cancer Image Figure 5. Solid Tumors Image Figure 6. Others Image Figure 7. Global Oncology Based Preclinical CRO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Oncology Based Preclinical CRO Market Share by Application: 2025 VS 2032 Figure 9. In Vitro Image Figure 10. In Vivo Image Figure 11. Global Oncology Based Preclinical CRO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 13. Global Oncology Based Preclinical CRO Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Oncology Based Preclinical CRO Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Oncology Based Preclinical CRO Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Oncology Based Preclinical CRO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2021-2032) Figure 20. Global Oncology Based Preclinical CRO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2021-2032) Figure 22. North America Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 23. North America Oncology Based Preclinical CRO Market Share by Type (2021-2032) Figure 24. North America Oncology Based Preclinical CRO Market Share by Application (2021-2032) Figure 25. North America Oncology Based Preclinical CRO Market Share by Country (2021-2032) Figure 26. United States Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 27. Canada Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 29. Europe Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 30. Europe Oncology Based Preclinical CRO Market Share by Type (2021-2032) Figure 31. Europe Oncology Based Preclinical CRO Market Share by Application (2021-2032) Figure 32. Europe Oncology Based Preclinical CRO Market Share by Country (2021-2032) Figure 33. Germany Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 34. France Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 36. Italy Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 37. Russia Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 39. China Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 40. China Oncology Based Preclinical CRO Market Share by Type (2021-2032) Figure 41. China Oncology Based Preclinical CRO Market Share by Application (2021-2032) Figure 42. Asia Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 43. Asia Oncology Based Preclinical CRO Market Share by Type (2021-2032) Figure 44. Asia Oncology Based Preclinical CRO Market Share by Application (2021-2032) Figure 45. Asia Oncology Based Preclinical CRO Market Share by Country (2021-2032) Figure 46. Japan Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 50. India Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 51. Australia Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Oncology Based Preclinical CRO Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Oncology Based Preclinical CRO Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Oncology Based Preclinical CRO Market Share by Country (2021-2032) Figure 56. Brazil Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 61. UAE Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 63. Chile Oncology Based Preclinical CRO Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Cancer
  • Solid Tumors
  • Others
Applications
  • In Vitro
  • In Vivo
Companies covered
  • Crown Bioscience
  • Charles River
  • ICON
  • Eurofins Scientific
  • Taconic Biosciences
  • Covance
  • EVOTEC
  • The Jackson Laboratory
  • MI Bioresearch
  • Champion Oncology
  • Wuxi AppTec.
  • Xentech
  • Living Tumor Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Blood Cancer
  5. 1.2.3 Solid Tumors
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 In Vitro
  10. 1.3.3 In Vivo
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Oncology Based Preclinical CRO Growth Trends by Region
  13. 1.5.1 Global Oncology Based Preclinical CRO Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Oncology Based Preclinical CRO Market Size by Region (2021-2026)
  15. 1.5.3 Oncology Based Preclinical CRO Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Oncology Based Preclinical CRO Market Dynamics
  1. 2.1 Oncology Based Preclinical CRO Industry Trends
  2. 2.2 Oncology Based Preclinical CRO Industry Drivers
  3. 2.3 Oncology Based Preclinical CRO Industry Opportunities and Challenges
  4. 2.4 Oncology Based Preclinical CRO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oncology Based Preclinical CRO Revenue by Company (2021-2026)
  2. 3.2 Global Oncology Based Preclinical CRO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oncology Based Preclinical CRO Key Company Head office and Area Served
  4. 3.4 Global Oncology Based Preclinical CRO Company, Product Type & Application
  5. 3.5 Global Oncology Based Preclinical CRO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oncology Based Preclinical CRO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oncology Based Preclinical CRO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oncology Based Preclinical CRO Tier 1, Tier 2, and Tier 3
4 Oncology Based Preclinical CRO Market by Type
  1. 4.1 Global Oncology Based Preclinical CRO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oncology Based Preclinical CRO Market Size by Type (2021-2032)
  3. 4.3 Global Oncology Based Preclinical CRO Market Size Share by Type (2021-2032)
5 Oncology Based Preclinical CRO Market by Application
  1. 5.1 Global Oncology Based Preclinical CRO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oncology Based Preclinical CRO Market Size by Application (2021-2032)
  3. 5.3 Global Oncology Based Preclinical CRO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Crown Bioscience
  2. 6.1.1 Crown Bioscience Company Information
  3. 6.1.2 Crown Bioscience Business Overview
  4. 6.1.3 Crown Bioscience Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Crown Bioscience Oncology Based Preclinical CRO Product Portfolio
  6. 6.1.5 Crown Bioscience Recent Developments
  7. 6.2 Charles River
  8. 6.2.1 Charles River Company Information
  9. 6.2.2 Charles River Business Overview
  10. 6.2.3 Charles River Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Charles River Oncology Based Preclinical CRO Product Portfolio
  12. 6.2.5 Charles River Recent Developments
  13. 6.3 ICON
  14. 6.3.1 ICON Company Information
  15. 6.3.2 ICON Business Overview
  16. 6.3.3 ICON Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ICON Oncology Based Preclinical CRO Product Portfolio
  18. 6.3.5 ICON Recent Developments
  19. 6.4 Eurofins Scientific
  20. 6.4.1 Eurofins Scientific Company Information
  21. 6.4.2 Eurofins Scientific Business Overview
  22. 6.4.3 Eurofins Scientific Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eurofins Scientific Oncology Based Preclinical CRO Product Portfolio
  24. 6.4.5 Eurofins Scientific Recent Developments
  25. 6.5 Taconic Biosciences
  26. 6.5.1 Taconic Biosciences Company Information
  27. 6.5.2 Taconic Biosciences Business Overview
  28. 6.5.3 Taconic Biosciences Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Taconic Biosciences Oncology Based Preclinical CRO Product Portfolio
  30. 6.5.5 Taconic Biosciences Recent Developments
  31. 6.6 Covance
  32. 6.6.1 Covance Company Information
  33. 6.6.2 Covance Business Overview
  34. 6.6.3 Covance Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Covance Oncology Based Preclinical CRO Product Portfolio
  36. 6.6.5 Covance Recent Developments
  37. 6.7 EVOTEC
  38. 6.7.1 EVOTEC Company Information
  39. 6.7.2 EVOTEC Business Overview
  40. 6.7.3 EVOTEC Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 EVOTEC Oncology Based Preclinical CRO Product Portfolio
  42. 6.7.5 EVOTEC Recent Developments
  43. 6.8 The Jackson Laboratory
  44. 6.8.1 The Jackson Laboratory Company Information
  45. 6.8.2 The Jackson Laboratory Business Overview
  46. 6.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 The Jackson Laboratory Oncology Based Preclinical CRO Product Portfolio
  48. 6.8.5 The Jackson Laboratory Recent Developments
  49. 6.9 MI Bioresearch
  50. 6.9.1 MI Bioresearch Company Information
  51. 6.9.2 MI Bioresearch Business Overview
  52. 6.9.3 MI Bioresearch Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 MI Bioresearch Oncology Based Preclinical CRO Product Portfolio
  54. 6.9.5 MI Bioresearch Recent Developments
  55. 6.10 Champion Oncology
  56. 6.10.1 Champion Oncology Company Information
  57. 6.10.2 Champion Oncology Business Overview
  58. 6.10.3 Champion Oncology Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Champion Oncology Oncology Based Preclinical CRO Product Portfolio
  60. 6.10.5 Champion Oncology Recent Developments
  61. 6.11 Wuxi AppTec.
  62. 6.11.1 Wuxi AppTec. Company Information
  63. 6.11.2 Wuxi AppTec. Business Overview
  64. 6.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Wuxi AppTec. Oncology Based Preclinical CRO Product Portfolio
  66. 6.11.5 Wuxi AppTec. Recent Developments
  67. 6.12 Xentech
  68. 6.12.1 Xentech Company Information
  69. 6.12.2 Xentech Business Overview
  70. 6.12.3 Xentech Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Xentech Oncology Based Preclinical CRO Product Portfolio
  72. 6.12.5 Xentech Recent Developments
  73. 6.13 Living Tumor Laboratory
  74. 6.13.1 Living Tumor Laboratory Company Information
  75. 6.13.2 Living Tumor Laboratory Business Overview
  76. 6.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Living Tumor Laboratory Oncology Based Preclinical CRO Product Portfolio
  78. 6.13.5 Living Tumor Laboratory Recent Developments
7 North America
  1. 7.1 North America Oncology Based Preclinical CRO Market Size (2021-2032)
  2. 7.2 North America Oncology Based Preclinical CRO Market Size by Type
  3. 7.2.1 North America Oncology Based Preclinical CRO Market Size by Type (2021-2026)
  4. 7.2.2 North America Oncology Based Preclinical CRO Market Size by Type (2027-2032)
  5. 7.2.3 North America Oncology Based Preclinical CRO Market Share by Type (2021-2032)
  6. 7.3 North America Oncology Based Preclinical CRO Market Size by Application
  7. 7.3.1 North America Oncology Based Preclinical CRO Market Size by Application (2021-2026)
  8. 7.3.2 North America Oncology Based Preclinical CRO Market Size by Application (2027-2032)
  9. 7.3.3 North America Oncology Based Preclinical CRO Market Share by Application (2021-2032)
  10. 7.4 North America Oncology Based Preclinical CRO Market Size by Country
  11. 7.4.1 North America Oncology Based Preclinical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oncology Based Preclinical CRO Market Size by Country (2021-2026)
  13. 7.4.3 North America Oncology Based Preclinical CRO Market Size by Country (2027-2032)
  14. 7.4.4 North America Oncology Based Preclinical CRO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oncology Based Preclinical CRO Market Size (2021-2032)
  2. 8.2 Europe Oncology Based Preclinical CRO Market Size by Type
  3. 8.2.1 Europe Oncology Based Preclinical CRO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oncology Based Preclinical CRO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oncology Based Preclinical CRO Market Share by Type (2021-2032)
  6. 8.3 Europe Oncology Based Preclinical CRO Market Size by Application
  7. 8.3.1 Europe Oncology Based Preclinical CRO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oncology Based Preclinical CRO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oncology Based Preclinical CRO Market Share by Application (2021-2032)
  10. 8.4 Europe Oncology Based Preclinical CRO Market Size by Country
  11. 8.4.1 Europe Oncology Based Preclinical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oncology Based Preclinical CRO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oncology Based Preclinical CRO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oncology Based Preclinical CRO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oncology Based Preclinical CRO Market Size (2021-2032)
  2. 9.2 China Oncology Based Preclinical CRO Market Size by Type
  3. 9.2.1 China Oncology Based Preclinical CRO Market Size by Type (2021-2026)
  4. 9.2.2 China Oncology Based Preclinical CRO Market Size by Type (2027-2032)
  5. 9.2.3 China Oncology Based Preclinical CRO Market Share by Type (2021-2032)
  6. 9.3 China Oncology Based Preclinical CRO Market Size by Application
  7. 9.3.1 China Oncology Based Preclinical CRO Market Size by Application (2021-2026)
  8. 9.3.2 China Oncology Based Preclinical CRO Market Size by Application (2027-2032)
  9. 9.3.3 China Oncology Based Preclinical CRO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oncology Based Preclinical CRO Market Size (2021-2032)
  2. 10.2 Asia Oncology Based Preclinical CRO Market Size by Type
  3. 10.2.1 Asia Oncology Based Preclinical CRO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oncology Based Preclinical CRO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oncology Based Preclinical CRO Market Share by Type (2021-2032)
  6. 10.3 Asia Oncology Based Preclinical CRO Market Size by Application
  7. 10.3.1 Asia Oncology Based Preclinical CRO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oncology Based Preclinical CRO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oncology Based Preclinical CRO Market Share by Application (2021-2032)
  10. 10.4 Asia Oncology Based Preclinical CRO Market Size by Country
  11. 10.4.1 Asia Oncology Based Preclinical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oncology Based Preclinical CRO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oncology Based Preclinical CRO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oncology Based Preclinical CRO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oncology Based Preclinical CRO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oncology Based Preclinical CRO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oncology Based Preclinical CRO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst